Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-12-05
2009-08-25
Goddard, Laura B (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007230
Reexamination Certificate
active
07579158
ABSTRACT:
The present invention relates to the diagnosis of breast cancer. It discloses the use of protein cellular retinoic acid binding protein II in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring cellular retinoic acid binding protein II in said sample. Measurement of cellular retinoic acid binding protein II can, e.g., be used in the early detection or diagnosis of breast cancer.
REFERENCES:
patent: 5871909 (1999-02-01), Astrom et al.
patent: 2003/0124128 (2003-07-01), Lillie et al.
patent: WO 00/60076 (2000-10-01), None
patent: WO 02/23200 (2002-03-01), None
patent: WO 02/059377 (2002-08-01), None
patent: WO 02/077176 (2002-10-01), None
patent: WO 02/101075 (2002-12-01), None
patent: WO 03004989 (2003-01-01), None
patent: WO 03004989 (2003-01-01), None
Clinton et al (Biomed Sci Instrum. 2003; 39:408-14).
Answers.com, “Blood”, p. 1-19.
Tockman et al (Cancer Res., 1992, 52:2711s-2718s).
Gaub et al (J of Histochemistry & Cytochemistry, 1998, 46:1103-1111).
Zeweig et al, Clinical Chemistry, 1993, 39:561-577.
Who, “Screening for Breast Cancer,” May 10, 2002.
Bruck, C. et al., “Purification of Mouse Monoclonal Antibodies from Ascitic Fluid by DEAE Affi-Gel Blue Chromatography,” Methods I Enzymology, vol. 12 (1986) 587-596.
Budhu, A. et al., “Direct Channeling of Retinoic Acid between Cellular Retinoic.Acid Receptor Sensitizes Mammary Carcinoma Cells to Retinoic Acid-Induced Growth Arrest,” Molecular and Cellular Biology, vol. 22, No. 8 Apr. 2002, p. 2632-2641.
Carney, P. et al., “Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography,” Ann Intern Med. 2003; 138: 168-175.
Chen, G. et al., “Discordant Protein and mRNA Expression in Lung Adenocarcinomas,” Molecular & Cellular Proteomics 1 (2002) 304-313.
Diamandis, E. et al., eds., Immunoassay, 1996, Academic Press, Boston.
Duffy, M.J. et al., “Clinical Uses of Tumor Markers: A Critical Review,” Critical Reviews in Clinical Laboratory Sciences, 38(3):225-262(2001).
Esserman, L. et al., “Improving the Accuracy of Mammography: Volume and Outcome Relationships,” Journal of the National Cancer Institute, vol. 94, No. 5, Mar. 6, 2002.
Galfre, G. et al., “Preparation of Monoclonal Antibodies: Strategies and Procedures,” Methods in Enzymology, vol. 73 (1981) 3-46.
Jing, Y. et al., “The Cellular Retinoic Acid Binding Protein II Is a Positive Regulator of Retinoic Acid Signaling in Breast Cancer Cells,” Cancer Research 57, 1668-1672, May 1, 1997.
Kleywegt, G. et al., “Crystal structures of cellular retinoic acid binding proteins I and II in complex with all-trans-retionic acid and a synthetic retinoid,” Structure 1994, vol. 2, No. 12, p. 1241-1258.
Kuerer, H. et al., “Identification of Distinct Protein Expression Patterns in Bilateral Matched Pair Breast Ductal Fluid Specimens from Women with Unilaterial Invasive Breast Carcinoma,” Cancer 95(2002) 2276-2282.
Siegenthaler, G. et al., “Expression of CRABP-1 and -II in Human Epidermal Cells,” Biochem, J. (1992) 287, 383-389.
Singletary, S. et al., “Revision of the American Joint Committee on Cancer Staging System for Breast Cancer,” Journal of Clinical Oncology, Vo. 20, No. 17 (Sep. 1, 2002)L pp. 3628-3636.
Sobin, L. H. et al., Wittekind, Ch. (eds): TNM Classification of Malignant Tumours, fifth edition, 1997.
Studier, F. et al., “Use of T7 RNA Polymerase to Direct Expression of Cloned Genes,” Methods in Enzymology, vol. 185 (1990) 60-89.
Tijssen, P. (1985) Practice and Theory of Enzyme Immunoassays, Elsevier, Amsterdam.
Untch, M. et al., “Tumor Markers in Breast Cancer,” J. Lab. Med. 25 (2001) 343-352.
Vahlquist, A. et al., “Increased Concentrations of 3, 4-Didehydroretinol and Retinoic Acid-Binding Protein (CRABPII) in Human Squamous Cell Carcinoma and Keratoacanthoma But Not in Basal Cell Carcinoma of the Skin,” Journal of Investigative Dermatology 106 (1996) 1070-1074.
Vo. H. et al., “Transcriptional Regulation of Retinoic Acid Responsive Genes by Cellular Retinoic Acid Binding Protein-II Modulates RA Mediated Tumor Cell Proliferation and Invasion,” Anticancer Research 18:217-224 (1998).
Wang, Y. et al., “Immunohistochemical Identification of Retinoic Acid Receptor {acute over (α)}(RAR{acute over (α)}) and Cellular Retinoic Acid Binding Protein H (CRABPH) in Human Breast Carcinoma,” Laboratory Investigation 78 (1889) 30 A.
Widschwendter, M. et al., “Interaction of Retinoic Acid and Interferon- {acute over (α)} in Breast Cancer Cell Lines,” Anticancer Research 16: 369-374 (1996).
Wulfkuhle, J. et al., “Proteomics of Human Breast Ductal Carcinoma in Situ,” Cancer Research 62, 6740-6749, Nov. 15, 2002.
Zweig, M. et al., “Receiver-Operating Characteristic (ROC) Plots: A Fundamental Evaluation Tool in Clinical Medicine,” Clin. Chem. 39/4, 561-577 (1993).
National Cancer Institute, Cancer Facts, Fact Sheet 5.18 (1998) 1-5.
Anderson, L., Seilhamer, J., “A comparison of selected mRNA and protein abundances in human liver”, Electrophoresis 1997, 18, 533-537.
Greenbaum, D., Colangelo, C., Williams, K., Gerstein, M., “Comparing protein abundance and mRNA expression levels on a genomic scale”, Genome Biology 2003, vol. 4, Issue 9, Article 117.1-117.8.
Gygi, S., Rochon, Y., Franza, B., Aebersold, R., “Correlation between Protein and mRNA Abundance in Yeast”, Molecular and Cellular Biology, Mar. 1999, pp. 1720-1730.
Andres Herbert
Berndt Peter
Hagmann Marie-Luise
Karl Johann
Langen Hanno
Amick Marilyn L.
Goddard Laura B
Roche Diagnostics Operations Inc.
Roche Diagnostics Operations Inc.
LandOfFree
Cellular retinoic acid binding protein II as a marker for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cellular retinoic acid binding protein II as a marker for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cellular retinoic acid binding protein II as a marker for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4084287